Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Research on Nanotoxicity of an Iron Oxide Nanoparticles and Potential Application

Ling Zhang, Hongmei Xie, Yingxun Liu and Jinke Wang

The iron oxide nanoparticles (FeNPs) are widely used in biomedicine for good biocompatibility. To promote its safe application, any potential nanotoxicity should be thoroughly and carefully investigated. This paper systematically summarizes our lab’s research on the nanotoxicity of iron oxide nanoparticles coated with dimercaptosuccinic acid (DMSA), including the effects of FeNPs on viability, apoptosis, cycle, and oxidative stress at cell level. In vitro studies revealed that the FeNPs showed obvious apoptosis of human acute monocyte cells (THP-1) and human hepatoma cells (HepG2) at the highest concentration. FeNPs resulted in common and cell typespecific nanotoxicities of the FeNPs to both human and mouse cells at the gene, disturbed cell’s iron and osmosis homeostasis by the internalization of FeNPs through releasing iron ion in cells, resulted in cytotoxicity of DMSA as coating molecules of FeNPs and the inhibitor of DNA binding/differentiation (Id) related nanotoxicity of FeNPs at gene level. The studies of our lab shed many new insights into the nanotoxicity of the nanoparticle. Furthermore, the toxicity may play more value if it is guided and applied reasonably, such as iron supplement, anti-oxidation, and immunotherapy.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.